Primary Site >> Pancreatic Cancer
Gene >> NOS2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Overexpression of endothelium-derived nitric oxide synthase isoform 3 in the vasculature of human pancreatic tumor biopsies. PMID: 9921950 |
Ref: Association of increased immunostaining for inducible nitric oxide synthase and nitrotyrosine with fibroblast growth factor transformation in pancreatic cancer. PMID: 10088562 Ref: Demonstration of iNOS-mRNA and iNOS in human monocytes stimulated with cancer cells in vitro. PMID: 10331487 |
Ref: Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages. PMID: 10646841 |
Ref: Regulation of interleukin-8 expression by nitric oxide in human pancreatic adenocarcinoma. PMID: 11506748 Ref: Inducible nitric oxide synthase (iNOS) immunoreactivity and its relationship to cell proliferation, apoptosis, angiogenesis, clinicopathologic characteristics, and patient survival in pancreatic cancer. PMID: 12067216 Ref: Inducible Nitric Oxide Synthase (iNOS) Immunoreactivity and Its Relationship to Cell Proliferation, Apoptosis, Angiogenesis, Clinicopathologic Characteristics, and Patient Survival in Pancreatic Cancer. PMID: 12754383 |
Ref: Role of cyclooxygenase-2 and inducible nitric oxide synthase in pancreatic cancer. PMID: 12164968 |
Ref: A novel model system for studying the double-edged roles of nitric oxide production in pancreatic cancer growth and metastasis. PMID: 12660813 |
Ref: Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. PMID: 14973050 Ref: Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer. PMID: 15165031 Ref: Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic adenocarcinoma: correlation with microvessel density. PMID: 15222037 |
Ref: Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer. PMID: 16638876 |
Ref: Increased expression of inducible nitric oxide synthase (iNOS) in N-nitrosobis(2-oxopropyl)amine-induced hamster pancreatic carcinogenesis and prevention of cancer development by ONO-1714, an iNOS inhibitor. PMID: 18567618 Ref: Prevention and treatment of pancreatic cancer by curcumin in combination with omega-3 fatty acids. PMID: 19003584 |
Ref: Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents. PMID: 22955327 |
Ref: Nitric oxide increases the invasion of pancreatic cancer cells via activation of the PI3K-AKT and RhoA pathways after carbon ion irradiation. PMID: 25019574 Ref: Serous neoplasms of the pancreas share many, but not all aspects of their microvascular and angiogenic profile with low-grade clear cell renal cell carcinomas. PMID: 25155377 Ref: Interaction between pancreatic cancer cells and tumor-associated macrophages promotes the invasion of pancreatic cancer cells and the differentiation and migration of macrophages. PMID: 25557640 |
Ref: Loss of SOD3 (EcSOD) Expression Promotes an Aggressive Phenotype in Human Pancreatic Ductal Adenocarcinoma. PMID: 25634994 |
Ref: Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer. PMID: 27367029 |
Ref: NO(*) and Pancreatic Cancer: A Complex Interaction with Therapeutic Potential. PMID: 27510096 Ref: Targeting iNOS to increase efficacy of immunotherapies. PMID: 28121247 |
Ref: Well differentiated grade 3 pancreatic neuroendocrine tumors compared with related neoplasms: A morphologic study. PMID: 29451738 Ref: Low dose radiation primed iNOS + M1macrophages modulate angiogenic programming of tumor derived endothelium. PMID: 30035346 |